Roche Holding AG RHHVF
472.77 USD +7.89 (+1.70%)
At closeNov 6, 2026, 4:00 PM EST
476.00 Day range 476.00
326.30 52-week range 487.52
- YTD
- +14.49%
- 1 year
- +44.89%
- Market cap
- 376.69B
- EPS (ttm)
- 19.32
- P/E ratio
- 24.47
- YTD return
- +14.49%
- 1-year return
- +44.89%
- Volume
- 39
- Avg volume
- 3.37K
- Open
- 476.00
- Previous close
- 464.88
- Day's range
- 476.00 – 476.00
- 52-week range
- 326.30 – 487.52
- Earnings date
- Feb 4, 2027
2Y +173.18 (+57.19%)
Next earnings
Feb 4, 2027
Expected Feb 4, 2027. Consensus EPS estimate 11.88.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 4, 2027 | Dec 30, 2026 | 11.88 | — | — | — |
| Jul 23, 2026 | Jun 30, 2026 | 12.51 | 13.42 | +0.91 | +7.27% |
| Jan 29, 2026 | Dec 31, 2025 | 10.83 | 10.56 | -0.27 | -2.49% |
| Jul 24, 2025 | Jun 30, 2025 | 13.18 | 13.97 | +0.79 | +5.99% |
| Jan 30, 2025 | Dec 31, 2024 | 9.25 | 9.44 | +0.19 | +2.05% |
| Jul 22, 2024 | Jun 30, 2024 | 10.42 | 11.38 | +0.96 | +9.21% |
News
Roche receives FDA 510(k) clearance for new cobas® eplex respiratory pathogen panel 3, enabling labs to customize respiratory testing for local patient needs 
Roche And Nurix Partner To Co-Develop BTK Degrader Bexobrutideg In $2.3B Deal Spanning Blood Cancers, Immunology And Neurology 
Stocks That Hit 52-Week Highs On Tuesday - Stocks That Hit 52-Week Highs On Wednesday
Stocks That Hit 52-Week Highs On Tuesday 
Stocks That Hit 52-Week Highs On Wednesday 
Stocks That Hit 52-Week Highs On Friday 
Stocks That Hit 52-Week Highs On Thursday 
Stocks That Hit 52-Week Highs On Wednesday - Stocks That Hit 52-Week Highs On Friday
Your note
Sign in to keep a note on RHHVF — it syncs with the Stock Master app.